Literature DB >> 8409450

Study of natural lipocortin I. A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice.

T Sakata1, S Iwagami, Y Tsuruta, S Suzuki, R Suzuki.   

Abstract

We previously reported a possible role of lipocortin I secreted from Mac-1+, -2+ macrophages in immunosuppression in tumor-bearing mice. In this study, we purified natural lipocortin I from the spleens of tumor-bearing mice and compared its immunosuppressive activity with recombinant lipocortin I produced by Escherichia coli. The culture supernatants of splenic macrophages from tumor-bearing mice suppressed the mitogenic responses in splenic lymphocytes. The culture supernatants contained higher levels of lipocortin I, but not PGE2, which was considered as a major immunosuppressive factor. Anti-lipocortin I antiserum neutralized these inhibitory activities. Natural lipocortin I purified from the spleens of tumor-bearing mice showed a potent suppressive activity, which was > or = 200 times higher than that of recombinant mouse lipocortin I at protein level. Alkaline phosphatase treatment of natural lipocortin I decreased immunosuppressive activity to the level of recombinant lipocortin I. N-glycosidase F treatment failed to decrease the immunosuppressive activities. These results suggest that the protein modification of lipocortin I, possibly phosphorylation but not glycosylation, is critical for the potent immunosuppressive activity in tumor-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409450

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Annexin V autoantibodies in rheumatoid arthritis.

Authors:  M I Rodríguez-García; J A Fernández; A Rodríguez; M P Fernández; C Gutierrez; J C Torre-Alonso
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

2.  Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

Authors:  Shu-Hsiang Liu; Chiao-Ying Lin; Shian-Yang Peng; Yung-Ming Jeng; Hung-Wei Pan; Po-Lin Lai; Chao-Lien Liu; Hey-Chi Hsu
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Identifying potential tumor markers and antigens by database mining and rapid expression screening.

Authors:  W T Loging; A Lal; I M Siu; T L Loney; C J Wikstrand; M A Marra; C Prange; D D Bigner; R L Strausberg; G J Riggins
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

4.  Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma.

Authors:  S D Pencil; M Toth
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

5.  Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes.

Authors:  A V Sampey; P Hutchinson; E F Morand
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

6.  Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex.

Authors:  T Aoe; Y Okamoto; T Saito
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.